REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Revert presented by the Catholic University of Murcia (UCAM) at the webinar: “Computational methods for drug discovery”

Revert, the European project financed by the European Commission under the Horizon 2020 call, participates through its partner  Catholic University of Murcia (UCAM) in the webinar: “Computational methods for drug discovery”. This seminar is part of a set of webinars developed by the Office for the Transfer of Research Results with the aim of disseminating science to research communities.This event showed the different computational methodologies for drug discovery developed by the UCAM BIO-HPC research group and how they have been applied to various academic and industrial projects.These video conference, organized jointly between UCAM and the Royal Academy of Medicine and Surgery of the Region of Murcia, were developed for 200 attendees (interested researchers, members of the Royal Academy of Medicine and Surgery and university students).

The presentation of the event was carried out by the Vice-Rector for Research, Dr. Estrella Núñez Delicado, and the President of the Royal Academy of Medicine and Surgery of the Region of Murcia, Dr. María Trinidad Herrero Ezquerro.

Subsequently, the different presentations on supercomputing began to be developed by the different researchers of the BIO-HPC Group:

Title of presentation: Is it possible to discover new drugs without stepping on the laboratory? Researcher: PhD. Horacio Pérez Sánchez. Doctor in Chemistry from the University of Murcia, Principal Investigator of the BIO-HPC group of UCAM.

In this presentation the PhD. Horacio Pérez showed the possibilities of drug discovery through screening, specifically virtual screening and its different techniques. The docking process was the center of the processes explained by the speaker during his talk, showing attendees the possibilities offered by this technique.

Title of presentation: Application of artificial intelligence to personalized medicine; H2020 REVERT project. Researcher:PhD. Antonio Jesús Banegas Luna. PhD in Computer Science from UCAM, Researcher of the UCAM BIO-HPC group.

This last presentation had as main focus the Revert project, showing the possibilities that artificial intelligence gives researchers to implement individualized medicine.

logo
logo-ce

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.

Copyright 2020 REVERT ©  All Rights Reserved